Prognostic relevance of [18F]FDG PET/CT in triple-negative breast cancer: Results from the triple negative (TRINE)-PET trial.
Journal: European journal of nuclear medicine and molecular imaging
•
Abstract
Abstract text is not embedded in this discovery record. Please consult the full-text publication via the source link on the right.
Subjects & Keywords
How to Cite this Article
Urso L, Panareo S, Albano D, et al. (2026). "Prognostic relevance of [18F]FDG PET/CT in triple-negative breast cancer: Results from the triple negative (TRINE)-PET trial.". European journal of nuclear medicine and molecular imaging. https://doi.org/10.1007/s00259-026-08056-1